BioCryst (BCRX) 8-K Summary

Date Filed: November 3, 2025

• Key Event: Disclosure of Third Quarter 2025 Financial Results and a concurrent corporate business update.
• Investor Action Required: All financial metrics, strategic developments, and guidance are located in the furnished Exhibit 99.1 press release.

This filing serves primarily as notification; the substance of performance and material changes rests in the referenced exhibit.

• The report itself contains no quantitative financial data or specific risk factors, merely referencing the attached press rel